[HT942526TBDRPTDRA] DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

Description

Titolo: DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award Numero dell'opportunità: HT942526TBDRPTDRA Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: Defense Health Agency Contracting Activity - DHACA — Department of Defense Tipo di finanziamento: Grant Categoria: Science and Technology and other Research and Development Programma (ALN): 12.420 Military Medical Research and Development Pubblicato il: 2026-05-05 Scadenza per le domande: 2026-10-22 Finanziamento totale stimato: 2,650,000 USD Numero di finanziamenti attesi: 2 Cofinanziamento richiesto: no Chi può fare domanda: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Descrizione: Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings. https://cdmrp.health.mil/pubs/press/2026/tbdrppreann Contatto: [email protected]

Sectors

Source

Source: grants.gov